Radiotherapy survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Organs at Risk Cell Line, Tumor Pelvis Lymph Nodes Bile Ducts, Intrahepatic Rectum

Organisms3

Mice, Inbred C57BL Mice, Nude Mice, Inbred BALB C

Diseases81

Radiation Injuries Neoplasm Recurrence, Local Lung Neoplasms Carcinoma, Squamous Cell Head and Neck Neoplasms Brain Neoplasms Nasopharyngeal Neoplasms Breast Neoplasms Adenocarcinoma Rectal Neoplasms Lymphatic Metastasis Carcinoma, Non-Small-Cell Lung Prostatic Neoplasms Neoplasms Liver Neoplasms Neoplasm Metastasis Carcinoma Hodgkin Disease Laryngeal Neoplasms Esophageal Neoplasms Neoplasms, Second Primary Pelvic Neoplasms Recurrence Radiation Pneumonitis Glioblastoma Disease Progression Sarcoma Bone Neoplasms Carcinoma, Hepatocellular Neoplasms, Radiation-Induced Neoplasm Invasiveness Glioma Pancreatic Neoplasms Radiodermatitis Spinal Neoplasms Postoperative Complications Xerostomia Stomach Neoplasms Uterine Cervical Neoplasms Supratentorial Neoplasms Hypopharyngeal Neoplasms Thoracic Neoplasms Carcinoma, Small Cell Central Nervous System Neoplasms Oropharyngeal Neoplasms Lymphoma, Non-Hodgkin Soft Tissue Neoplasms Bile Duct Neoplasms Colorectal Neoplasms Melanoma Astrocytoma Nose Neoplasms Testicular Neoplasms Mouth Neoplasms Rhabdomyosarcoma Medulloblastoma Cholangiocarcinoma Osteoradionecrosis Skin Neoplasms Skull Base Neoplasms Cerebellar Neoplasms Esthesioneuroblastoma, Olfactory Kidney Neoplasms Osteosarcoma Mucositis Meningeal Neoplasms Stomatitis Neoplasm, Residual Disease Models, Animal Lymphoma Pharyngeal Neoplasms Brain Stem Neoplasms Abdominal Neoplasms Urinary Bladder Neoplasms Oligodendroglioma Ependymoma Seminoma Ovarian Neoplasms Carcinoma, Adenosquamous Anus Neoplasms Orbital Neoplasms

Chemicals and Drugs42

Cisplatin Antineoplastic Agents Vincristine Fluorouracil Radiation-Sensitizing Agents Doxorubicin Cyclophosphamide Dacarbazine Tumor Markers, Biological Procarbazine Prednisone Bleomycin Etoposide Vinblastine Mechlorethamine Cobalt Radioisotopes Antineoplastic Agents, Alkylating Radiation-Protective Agents Carboplatin Deoxycytidine Antimetabolites, Antineoplastic Methotrexate Iridium Radioisotopes Lomustine Androgen Antagonists Vindesine Nimustine Paclitaxel Radiopharmaceuticals Ifosfamide Prostate-Specific Antigen Antineoplastic Agents, Hormonal Antibodies, Monoclonal Amifostine Taxoids Leucovorin Mitomycin Antineoplastic Agents, Phytogenic Organoplatinum Compounds Fluorodeoxyglucose F18 Antibodies, Monoclonal, Humanized Tumor Suppressor Protein p53

Analytical, Diagnostic and Therapeutic Techniques and Equipment99

Radiotherapy Survival Rate Radiotherapy Dosage Radiotherapy, Adjuvant Radiotherapy, Conformal Combined Modality Therapy Radiotherapy, Intensity-Modulated Disease-Free Survival Radiotherapy, High-Energy Survival Analysis Radiotherapy Planning, Computer-Assisted Treatment Outcome Dose Fractionation Retrospective Studies Neoplasm Staging Radiotherapy, Computer-Assisted Prognosis Radiotherapy, Image-Guided Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Brachytherapy Radiosurgery Dose-Response Relationship, Radiation Chemoradiotherapy Chemotherapy, Adjuvant Proportional Hazards Models Prospective Studies Multivariate Analysis Cranial Irradiation Neoadjuvant Therapy Actuarial Analysis Risk Factors Tomography, X-Ray Computed Particle Accelerators Radiation Dosage Drug Administration Schedule Palliative Care Mastectomy, Segmental Radiometry Remission Induction Salvage Therapy Radioisotope Teletherapy Cohort Studies Immunohistochemistry Organ Sparing Treatments Tumor Burden Heavy Ion Radiotherapy Lymph Node Excision Risk Assessment Mastectomy Lymphatic Irradiation Treatment Failure Registries Feasibility Studies Preoperative Care Predictive Value of Tests Liver Transplantation Chemoradiotherapy, Adjuvant Postoperative Care SEER Program Laryngectomy Clinical Trials as Topic Incidence Hepatectomy Reoperation Positron-Emission Tomography Probability Life Tables Neoplasm Grading Patient Selection Postoperative Period Pneumonectomy Randomized Controlled Trials as Topic Analysis of Variance Gastrectomy Kidney Transplantation Patient Positioning Chemoembolization, Therapeutic Prostatectomy Magnetic Resonance Imaging Hyperthermia, Induced Radiotherapy Setup Errors Fiducial Markers Chi-Square Distribution Disease Models, Animal Mastectomy, Modified Radical Esophagectomy Transplantation, Homologous Induction Chemotherapy Proton Therapy Cryopreservation Neck Dissection Cause of Death Risk Biopsy Pilot Projects Infusions, Intravenous Eye Enucleation

Phenomena and Processes18

Cell Survival Time Factors Graft Survival Dose-Response Relationship, Radiation Radiation Tolerance Radiation Dosage Apoptosis Probability Cell Proliferation Signal Transduction Dose-Response Relationship, Drug Gene Expression Regulation, Neoplastic Heavy Ions Chi-Square Distribution Graft Rejection Radiation, Ionizing Risk Gamma Rays

Disciplines and Occupations3

Radiation Oncology Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science10

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, Computer-Assisted Registries SEER Program Incidence Life Tables Cause of Death

Named Groups1

Health Care41

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Retrospective Studies Radiation Injuries Follow-Up Studies Kaplan-Meier Estimate Dose-Response Relationship, Radiation Proportional Hazards Models Prospective Studies Multivariate Analysis Actuarial Analysis Risk Factors Radiation Dosage Palliative Care Age Factors Cohort Studies Risk Assessment Treatment Failure Registries Feasibility Studies Preoperative Care Predictive Value of Tests Postoperative Care SEER Program Clinical Trials as Topic Incidence Probability Life Tables Patient Selection Postoperative Period Cancer Care Facilities Randomized Controlled Trials as Topic Analysis of Variance Patient Positioning Radiotherapy Setup Errors Chi-Square Distribution Cause of Death Risk Pilot Projects

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Radiotherapy Survival Rate Radiotherapy Dosage Radiotherapy, Adjuvant Radiotherapy, Conformal Combined Modality Therapy Radiotherapy, Intensity-Modulated Disease-Free Survival Radiotherapy, High-Energy Cell Survival Survival Analysis Radiotherapy Planning, Computer-Assisted Treatment Outcome Dose Fractionation Retrospective Studies Neoplasm Staging Radiation Injuries Radiotherapy, Computer-Assisted Prognosis Neoplasm Recurrence, Local Radiotherapy, Image-Guided Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Survival Kaplan-Meier Estimate Time Factors Lung Neoplasms Graft Survival Carcinoma, Squamous Cell Head and Neck Neoplasms Radiation Oncology Brachytherapy Radiosurgery Dose-Response Relationship, Radiation Chemoradiotherapy Chemotherapy, Adjuvant Brain Neoplasms Cisplatin Nasopharyngeal Neoplasms Proportional Hazards Models Breast Neoplasms Adenocarcinoma Rectal Neoplasms Antineoplastic Agents Vincristine Radiation Tolerance Lymphatic Metastasis Fluorouracil Radiation-Sensitizing Agents Prospective Studies Multivariate Analysis Carcinoma, Non-Small-Cell Lung Prostatic Neoplasms Cranial Irradiation Neoadjuvant Therapy Neoplasms Liver Neoplasms Actuarial Analysis Organs at Risk Neoplasm Metastasis Carcinoma Doxorubicin Hodgkin Disease Laryngeal Neoplasms Cyclophosphamide Risk Factors Esophageal Neoplasms Dacarbazine Tomography, X-Ray Computed Particle Accelerators Tumor Markers, Biological Radiation Dosage Neoplasms, Second Primary Drug Administration Schedule Pelvic Neoplasms Palliative Care Procarbazine Mastectomy, Segmental Radiometry Remission Induction Salvage Therapy Recurrence Radiation Pneumonitis Glioblastoma Disease Progression Sarcoma Age Factors Prednisone Radioisotope Teletherapy Cohort Studies Immunohistochemistry Apoptosis Bone Neoplasms Organ Sparing Treatments Bleomycin Etoposide Vinblastine Cell Line, Tumor Carcinoma, Hepatocellular Neoplasms, Radiation-Induced

No FAQ available that match "radiotherapy survival rate"